An evaluation of rectal artesunate for the pre-hospital management of severe malaria

References

• WHO. World malaria report. Geneva: World Health Organisation; 2018. p. 210.
   Google Scholar
• Chukwuocha UM, Okpanma AC, Nwakwuo GC, et al. Determinants of delay in seeking malaria treatment for children under-five years in parts of South Eastern Nigeria. J Community Health. 2014;39(6):1171–1178.
   PubMed Web of Science ®Google Scholar
• FDA. FDA briefing document for the anti-infective drug products advisory committee. Artesunate rectal capsules World Health Organization NDA 21-242. Washington, DC: U.S. Food and Drug Administration, Center for Drug Evaluation and Research, Division of Special Pathogen and Immunologic Drug Products; 2002. p. 37.
   Google Scholar
• WHO. Guidelines for the treatment of malaria. Third ed. Geneva: World Health Organisation; 2015. p. 316.
   Google Scholar
• MMV. Severe malaria observatory RAS market dynamics. 2017 1/100/17. [cited 2020 Jan 8]. Available from: https://www.severemalaria.org/drugs-markets/rectal-artesunate/ras-market-dynamics
   Google Scholar
• German PI, Aweeka FT. Clinical pharmacology of artemisinin-based combination therapies. Clin Pharmacokinet. 2008;47(2):91–102.
   PubMed Web of Science ®Google Scholar
• Eastman RT, Fidock DA. Artemisinin-based combination therapies: a vital tool in efforts to eliminate malaria. Nat Rev Microbiol. 2009;7(12):864–874.
   PubMed Web of Science ®Google Scholar
• Haynes RK, Cheu KW, N’Da D, et al. Considerations on the mechanism of action of artemisinin antimalarials: part 1–the ‘carbon radical’ and ‘heme’ hypotheses. Infect Disord Drug Targets. 2013;13(4):217–277.
   PubMedGoogle Scholar
• Cui L, Su XZ. Discovery, mechanisms of action and combination therapy of artemisinin. Expert Rev Anti Infect Ther. 2009;7(8):999–1013.
   PubMed Web of Science ®Google Scholar
• Amato R, Pearson RD, Almagro-Garcia J, et al. Origins of the current outbreak of multidrug-resistant malaria in southeast Asia: a retrospective genetic study. Lancet Infect Dis. 2018;18(3):337–345.
   PubMed Web of Science ®Google Scholar
• Kouakou YI, Tod M, Leboucher G, et al. Systematic review of artesunate pharmacokinetics: implication for treatment of resistant malaria. Int J Infect Dis. 2019;89:30–44.
   PubMed Web of Science ®Google Scholar
• Hess KM, Goad JA, Arguin PM. Intravenous artesunate for the treatment of severe malaria. Ann Pharmacother. 2010;44(7–8):1250–1258.
   PubMed Web of Science ®Google Scholar
• Newton PN, Barnes KI, Smith PJ, et al. The pharmacokinetics of intravenous artesunate in adults with severe falciparum malaria. Eur J Clin Pharmacol. 2006;62(12):1003–1009.
   PubMed Web of Science ®Google Scholar
• Morris CA, Duparc S, Borghini-Fuhrer I, et al. Review of the clinical pharmacokinetics of artesunate and its active metabolite dihydroartemisinin following intravenous, intramuscular, oral or rectal administration. Malar J. 2011;10:263.
   PubMed Web of Science ®Google Scholar
• Sirivichayakul C, Sabchareon A, Pengsaa K, et al. Comparative study of the effectiveness and pharmacokinetics of two rectal artesunate/oral mefloquine combination regimens for the treatment of uncomplicated childhood falciparum malaria. Ann Trop Paediatr. 2007;27(1):17–24.
   PubMed Web of Science ®Google Scholar
• Halpaap B, Ndjave M, Paris M, et al. Plasma levels of artesunate and dihydroartemisinin in children with Plasmodium falciparum malaria in Gabon after administration of 50-milligram artesunate suppositories. Am J Trop Med Hyg. 1998;58(3):365–368.
   PubMed Web of Science ®Google Scholar
• Dondorp AM, Ince C, Charunwatthana P, et al. Direct in vivo assessment of microcirculatory dysfunction in severe falciparum malaria. J Infect Dis. 2008;197(1):79–84.
   PubMed Web of Science ®Google Scholar
• Krishna S, Planche T, Agbenyega T, et al. Bioavailability and preliminary clinical efficacy of intrarectal artesunate in Ghanaian children with moderate malaria. Antimicrob Agents Chemother. 2001;45(2):509–516.
   PubMed Web of Science ®Google Scholar
• Awad MI, Eltayeb IB, Baraka OZ, et al. Pharmacokinetics of artesunate following oral and rectal administration in healthy Sudanese volunteers. Trop Doct. 2004;34(3):132–135.
   PubMed Web of Science ®Google Scholar
• Navaratnam V, Mansor SM, Mordi MN, et al. Comparative pharmacokinetic study of oral and rectal formulations of artesunic acid in healthy volunteers. Eur J Clin Pharmacol. 1998;54(5):411–414.
   PubMed Web of Science ®Google Scholar
• Ilett KF, Batty KT, Powell SM, et al. The pharmacokinetic properties of intramuscular artesunate and rectal dihydroartemisinin in uncomplicated falciparum malaria. Br J Clin Pharmacol. 2002;53(1):23–30.
   PubMed Web of Science ®Google Scholar
• Simpson JA, Agbenyega T, Barnes KI, et al. Population pharmacokinetics of artesunate and dihydroartemisinin following intra-rectal dosing of artesunate in malaria patients. PLoS Med. 2006;3(11):e444.
   PubMed Web of Science ®Google Scholar
• Karunajeewa HA, Ilett KF, Dufall K, et al. Disposition of artesunate and dihydroartemisinin after administration of artesunate suppositories in children from Papua New Guinea with uncomplicated malaria. Antimicrob Agents Chemother. 2004;48(8):2966–2972.
   PubMed Web of Science ®Google Scholar
• Barnes KI, Mwenechanya J, Tembo M, et al. Efficacy of rectal artesunate compared with parenteral quinine in initial treatment of moderately severe malaria in African children and adults: a randomised study. Lancet. 2004;363(9421):1598–1605.
   PubMed Web of Science ®Google Scholar
• Gomes M, Faiz MA, Gyapong JO, et al. Pre-referral rectal artesunate to prevent death and disability in severe malaria: a placebo-controlled trial. Lancet. 2009;373(9663):557–566.
   PubMed Web of Science ®Google Scholar
• Hirji KF, Premji ZG. Pre-referral rectal artesunate in severe malaria: flawed trial. Trials. 2011;12:188.
   PubMed Web of Science ®Google Scholar
• Gomes M. Response to: pre-referral rectal artesunate in severe malaria: a flawed trial. Trials. 2011;12:189.
   PubMed Web of Science ®Google Scholar
• Okebe J, Eisenhut M. Pre-referral rectal artesunate for severe malaria.. Cochrane Database Syst Rev. 2014;(5):CD009964.
   PubMed Web of Science ®Google Scholar
• Phiri TB, Kaunda-Khangamwa BN, Bauleni A, et al. Feasibility, acceptability and impact of integrating malaria rapid diagnostic tests and pre-referral rectal artesunate into the integrated community case management programme. A pilot study in Mchinji district, Malawi. Malar J. 2016;15:177.
   PubMed Web of Science ®Google Scholar
• Siribié M, Ajayi IO, Nsungwa-Sabiiti J, et al. Compliance with referral advice after treatment with prereferral rectal artesunate: a study in 3 Sub-Saharan African Countries. Clin Infect Dis. 2016;63(suppl 5):S283–S289.
   PubMed Web of Science ®Google Scholar
• Strachan CE, Nuwa A, Muhangi D, et al. Community understanding of the concept of pre-referral treatment and how this impacts on referral related decision-making following the provision of rectal artesunate: a qualitative study in western Uganda. BMC Health Serv Res. 2018;18(1):470.
   PubMed Web of Science ®Google Scholar
• Lal S, Ndyomugenyi R, Paintain L, et al. Caregivers’ compliance with referral advice: evidence from two studies introducing mRDTs into community case management of malaria in Uganda. BMC Health Serv Res. 2018;18(1):317.
   PubMed Web of Science ®Google Scholar
• Warsame M, Gyapong M, Mpeka B, et al. Pre-referral rectal artesunate treatment by community-based treatment providers in Ghana, Guinea-Bissau, Tanzania, and Uganda (study 18): a cluster-randomized trial. Clin Infect Dis. 2016;63(suppl 5):S312–S321.
   PubMed Web of Science ®Google Scholar
• Gomes M, Ribeiro I, Warsame M, et al. Rectal artemisinins for malaria: a review of efficacy and safety from individual patient data in clinical studies. BMC Infect Dis. 2008;8:39.
   PubMed Web of Science ®Google Scholar
• Inthavilay S, Franchard T, Meimei Y, et al. Knowledge and acceptability of the rectal treatment route in Laos and its application for pre-referral emergency malaria treatment. Malar J. 2010;9:342.
   PubMed Web of Science ®Google Scholar
• Tozan Y, Klein EY, Darley S, et al. Prereferral rectal artesunate for treatment of severe childhood malaria: a cost-effectiveness analysis. Lancet. 2010;376(9756):1910–1915.
   PubMed Web of Science ®Google Scholar
• Castellani J, Mihaylova B, Siribié M, et al. Household costs and time to treatment for children with severe febrile illness in rural Burkina Faso: the role of rectal artesunate. Malar J. 2018;17(1):380.
   PubMed Web of Science ®Google Scholar
• Dondorp AM, Fanello CI, Hendriksen IC, et al. Artesunate versus quinine in the treatment of severe falciparum malaria in African children (AQUAMAT): an open-label, randomised trial. Lancet. 2010;376(9753):1647–1657.
   PubMed Web of Science ®Google Scholar
• Sinclair D, Donegan S, Isba R, et al. Artesunate versus quinine for treating severe malaria. Cochrane Database Syst Rev. 2012;(6):CD005967.
   PubMed Web of Science ®Google Scholar
• Barnes KI, Watkins WM, White NJ. Antimalarial dosing regimens and drug resistance. Trends Parasitol. 2008;24(3):127–134.
   PubMed Web of Science ®Google Scholar
• Hawkes MT, Forgie S, Brophy J, et al. Artesunate treatment of severe pediatric malaria: a review of parasite clearance kinetics and clinical implications. Can J Infect Dis Med Microbiol. 2015;26(5):237–240.
   PubMed Web of Science ®Google Scholar
• Hawkes M, Conroy AL, Opoka RO, et al. Slow clearance of plasmodium falciparum in severe pediatric malaria, Uganda, 2011–2013. Emerg Infect Dis. 2015;21(7):1237–1239.
   PubMed Web of Science ®Google Scholar
• MMV. Rectal artesunate (RAS). 2019 Oct [cited 2020 Jan 8]. Available from: https://www.mmv.org/access/products-projects/rectal-artesunate-ras
   Google Scholar